Nicholas M. Westfall - 01 Jun 2023 Form 4 Insider Report for CHEMED CORP (CHE)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Jun 2023, 15:10:32 UTC
Prior SEC filing
01 Jun 2023
Next SEC filing
26 Oct 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Nicholas M. Westfall

Key filing fact

Nicholas M. Westfall filed Form 4 for CHEMED CORP (CHE) on 05 Jun 2023.

Key facts

  • This page summarizes Nicholas M. Westfall's Form 4 filing for CHEMED CORP (CHE).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 05 Jun 2023, 15:10.

Change

  • Previous filing in this sequence was filed on 01 Jun 2023.
  • Current net transaction value: -$6,761,979.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CHE transaction

capital stock

Options Exercise

Transaction value
$5,235,117
Shares
+12,670
Change %
+165%
Price
$413.19
Shares after
20,346
Date
01 Jun 2023
Ownership
Direct
CHE transaction

capital stock

Sale

Transaction value
$6,761,979
Shares
-12,670
Change %
-62%
Price
$533.70
Shares after
7,676
Date
01 Jun 2023
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CHE transaction Derivative

stock option(right to buy with tandem tax withholding)

Options Exercise

Transaction value
$5,235,117
Shares
-12,670
Change %
-21%
Price
$413.19
Shares after
46,399
Date
01 Jun 2023
Ownership
Direct
Underlying class
capital stock
Underlying amount
12,670
Exercise price
$413.19
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.00 to $535.34. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Footnote F2

Vesting in three equal annual installments commencing 10/29/2020

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .